Crypto futures expansion follows 139% growth in trading as regulated products draw rising institutional and retail demand American financial services firm CME GroupCrypto futures expansion follows 139% growth in trading as regulated products draw rising institutional and retail demand American financial services firm CME Group

CME Group to Launch ADA, LINK, and XLM Futures as Crypto Trading Surges

Crypto futures expansion follows 139% growth in trading as regulated products draw rising institutional and retail demand

American financial services firm CME Group is preparing to expand its regulated crypto derivatives offering. New contracts tied to Cardano, Chainlink, and Stellar are set to launch in February, following strong growth in crypto futures activity. The move comes as both institutional and retail traders seek regulated venues to manage risk while increasing exposure to digital assets.

CME Group Adds New Crypto Futures as Demand for Regulated Products Grows

CME Group announced plans to launch futures contracts for Cardano (ADA), Chainlink (LINK), and Stellar (XLM) on February 9. The contracts will be regulated by the US Commodity Futures Trading Commission, offering market participants access to products that meet US regulatory standards.

Moreover, the exchange aims to offer trading flexibility to market participants. As such, it will list both standard-sized and micro-sized futures for each token:

  • Cardano futures (100,000 ADA), alongside Micro ADA futures (10,000 ADA). 
  • Chainlink contracts (5,000 LINK futures) and Micro LINK futures (250 LINK). 
  • Stellar, also known as Lumens (250,000 Lumens), with micro Lumens (12,500 Lumens).

CME Group’s crypto futures offering already spans Bitcoin, Ether, XRP, and Solana, alongside options on futures. With the latest additions, the exchange said institutional price discovery will extend across various digital assets.

Crypto Futures Activity Surges 139% Year Over Year at CME Group

According to reports, the CME Group’s expansion follows a 139% year-over-year increase in crypto futures trading activity. Market interest has continued to grow as digital assets gain wider acceptance among both institutional and retail investors.

Giovanni Vicioso, Global Head of Cryptocurrency Products at CME Group, said strong client demand drove the decision. Growing activity across crypto markets over the past year increased interest in regulated products that help manage price swings. Many traders, he added, are turning to trusted venues to hedge risk and gain market exposure.

Martin Franchi, Chief Executive Officer of NinjaTrader, described the launch as a major step for the futures industry. He said digital assets are moving deeper into global investment portfolios, with futures trading becoming more common among individual traders.

In addition, Justin Young, CEO and Co-Founder of Volatility Shares, also welcomed the move. The CEO said the firm is keen to see a broader range of regulated products that support trading and risk management in crypto markets.

New 100-Ounce Silver Futures Set to Launch

Alongside the crypto launch, CME Group confirmed plans to launch a 100-ounce silver futures contract on February 9. The contract will be financially settled based on the daily settlement price of the benchmark silver futures contract. It will also be listed under COMEX rules.

Jin Hennig, Managing Director and Global Head of Metals at CME Group, said silver is gaining interest from retail traders looking to diversify their portfolios. Rising demand helped drive record trading volumes in 2025 for Micro Gold and Micro Silver futures. The company recorded more than six million contracts traded in 1-ounce gold futures since its launch last year.

Image by CME Group

The post CME Group to Launch ADA, LINK, and XLM Futures as Crypto Trading Surges appeared first on Live Bitcoin News.

Market Opportunity
Stellar Logo
Stellar Price(XLM)
$0.2263
$0.2263$0.2263
-1.99%
USD
Stellar (XLM) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23